Table 3. Pathological results of the lesions (n=42).
| Pathological result | N (%) |
|---|---|
| Surgical margin | |
| Negative cases | 31 (100.0) |
| Positive cases | 0 (0.0) |
| Pathological diagnosis | |
| Benign | |
| AAH | 5 (11.9) |
| DIPNECH | 1 (2.4) |
| CIP | 3 (7.1) |
| Fibrosis | 2 (4.8) |
| Hamartoma | 1 (2.4) |
| OP | 2 (4.8) |
| Malignant | |
| AIS | 12 (28.6) |
| IA | 4 (9.5) |
| MIA | 5 (11.9) |
| MLC | 5 (11.9) |
| NSCPDA | 2 (4.8) |
AAH, atypical adenomatous hyperplasia; AIS, adenocarcinoma in situ; DIPNECH, diffuse interstitial pulmonary neuroendocrine cell hyperplasia; CIP, chronic interstitial pneumonia; IA, invasive adenocarcinoma; MIA, minimally invasive adenocarcinoma; MLC, metastatic lung cancer; NSCPDA, Non-small cell poorly differentiated adenocarcinoma; OP, organized pneumonia.